Invivyd, Inc.
NGM: IVVDLive Quote
📈 ZcoreAI Score
Our AI model analyzes Invivyd, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get IVVD Z-Score →About Invivyd, Inc.
Healthcare
Biotechnology
Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal antibody for the pre-exposure prophylaxis prevention of COVID-19 in adults and adolescents through injection under the PEMGARDA brand. It also develops VYD2311, a monoclonal antibody, which is in Phase III clinical trial for the prevention and treatment of SARS-CoV-2 virus; and VBY329, a monoclonal antibody, which is in pre-clinical trial stage for the prevention and treatment of respiratory syncytial virus and measles in neonates, infants, and children. It has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. The company was formerly known as Adagio Therapeutics, Inc. and changed its name to Invivyd, Inc. in September 2022. Invivyd, Inc. was incorporated in 2020 and is headquartered in New Haven, Connecticut.
📊 Fundamental Analysis
Invivyd, Inc. demonstrates a profit margin of -98.2%, which is below the sector average, suggesting competitive pressure.
The company recently reported 24.5% revenue growth, which is well above average for the Healthcare sector.
Return on Equity (ROE) is -34.0%, which indicates that capital utilization is currently under pressure.
At a current price of $1.76, IVVD currently sits at the 50th percentile of its 52-week range (Range: $0.46 - $3.07).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
✅
Beta (Risk)
Low Volatility
Key Financials
Market Cap
$497.73M
Trailing P/E
--
Forward P/E
-8.00
Beta (5Y)
0.74
52W High
$3.07
52W Low
$0.46
Avg Volume
3.20M
Day High
Day Low